https://doi.org/10.1021/bi901786x
C
Colin A. Flaveny
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
3.7K
Citations
23
h-index
29
i10-index
Colin A. Flaveny is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Hedgehog Signaling Pathway Studies & Epigenetics and DNA Methylation & Cancer, Hypoxia, and Metabolism. The author has an h-index of 23, co-authored 72 publications.
ORCID: 0000-0002-5391-715XPapers by this author
worksThe Uremic Toxin 3-Indoxyl Sulfate Is a Potent Endogenous Agonist for the Human Aryl Hydrocarbon Receptor
2009 · Biochemistry · 309 citations
Differential Gene Regulation by the Human and Mouse Aryl Hydrocarbon Receptor
2009 · Toxicological Sciences · 101 citations
https://doi.org/10.1093/toxsci/kfp308
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis
2015 · Molecular Metabolism · 86 citations
https://doi.org/10.1016/j.molmet.2015.01.009
Pyrvinium Attenuates Hedgehog Signaling Downstream of Smoothened
2014 · Cancer Research · 74 citations
https://doi.org/10.1158/0008-5472.can-14-0317
LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer
2019 · Scientific Reports · 61 citations
https://doi.org/10.1038/s41598-019-56038-1
The mouse and human Ah receptor differ in recognition of LXXLL motifs
2008 · Archives of Biochemistry and Biophysics · 48 citations
https://doi.org/10.1016/j.abb.2008.01.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat